386 related articles for article (PubMed ID: 37985986)
1. Association between diet soft drink consumption and metabolic dysfunction-associated steatotic liver disease: findings from the NHANES.
Wu Y; Tan Z; Zhen J; Liu C; Zhang J; Liao F; Dong W
BMC Public Health; 2023 Nov; 23(1):2286. PubMed ID: 37985986
[TBL] [Abstract][Full Text] [Related]
2. Trends in Oxidative Balance Score and Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in the United States: National Health and Nutrition Examination Survey 2001 to 2018.
Tan Z; Wu Y; Meng Y; Liu C; Deng B; Zhen J; Dong W
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068789
[TBL] [Abstract][Full Text] [Related]
3. Association between Alcohol Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Alcohol Flushing Response in Men: The Korea National Health and Nutrition Examination Survey 2019-2021.
Kang DE; Oh SN
Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764685
[TBL] [Abstract][Full Text] [Related]
4. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
Abid A; Taha O; Nseir W; Farah R; Grosovski M; Assy N
J Hepatol; 2009 Nov; 51(5):918-24. PubMed ID: 19765850
[TBL] [Abstract][Full Text] [Related]
5. Extent to which weight loss contributes to improving metabolic dysfunction-associated and metabolic and alcohol related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups.
Fukuda T; Okamoto T; Fukaishi T; Kawakami A; Tanaka M; Yamada T; Monzen K
Front Endocrinol (Lausanne); 2024; 15():1392280. PubMed ID: 38779448
[TBL] [Abstract][Full Text] [Related]
6. Association of physical activity with MAFLD/MASLD and LF among adults in NHANES, 2017-2020.
Li M
Wien Klin Wochenschr; 2024 May; 136(9-10):258-266. PubMed ID: 38170220
[TBL] [Abstract][Full Text] [Related]
7. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.
Younossi ZM; Paik JM; Stepanova M; Ong J; Alqahtani S; Henry L
J Hepatol; 2024 May; 80(5):694-701. PubMed ID: 38286339
[TBL] [Abstract][Full Text] [Related]
8. Association between the composite dietary antioxidant index and metabolic dysfunction-associated steatotic liver disease in adults: a cross-sectional study from NHANES 2017-2020.
Yang Z; Song S; Li L; Yuan Z; Li Y
Sci Rep; 2024 Jun; 14(1):13801. PubMed ID: 38877074
[TBL] [Abstract][Full Text] [Related]
9. Exploring the landscape of steatotic liver disease in the general US population.
Ciardullo S; Carbone M; Invernizzi P; Perseghin G
Liver Int; 2023 Nov; 43(11):2425-2433. PubMed ID: 37592856
[TBL] [Abstract][Full Text] [Related]
10. Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study.
Zhang S; Gu Y; Bian S; Lu Z; Zhang Q; Liu L; Meng G; Yao Z; Wu H; Wang Y; Zhang T; Wang X; Sun S; Wang X; Zhou M; Jia Q; Song K; Qi L; Niu K
Am J Clin Nutr; 2021 May; 113(5):1265-1274. PubMed ID: 33564868
[TBL] [Abstract][Full Text] [Related]
11. Relationship between high fructose corn syrup sweetened drinks, diet soft drinks, and serum sodium: NHANES 2003-2006.
Li M; Gong W; Wang S; Li Z
Nutr J; 2022 Dec; 21(1):76. PubMed ID: 36581871
[TBL] [Abstract][Full Text] [Related]
12. Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database.
Nemer M; Osman F; Said A
Ann Hepatol; 2024; 29(3):101491. PubMed ID: 38412922
[TBL] [Abstract][Full Text] [Related]
13. Diet soft drink consumption is associated with an increased risk of vascular events in the Northern Manhattan Study.
Gardener H; Rundek T; Markert M; Wright CB; Elkind MS; Sacco RL
J Gen Intern Med; 2012 Sep; 27(9):1120-6. PubMed ID: 22282311
[TBL] [Abstract][Full Text] [Related]
14. Diet Soft Drink Consumption is Associated with the Metabolic Syndrome: A Two Sample Comparison.
Crichton G; Alkerwi A; Elias M
Nutrients; 2015 May; 7(5):3569-86. PubMed ID: 25984744
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional survey.
Enriquez R; Homsi M; Ssekubugu R; Nabukalu D; Zeebari Z; Marrone G; Gigante B; Chang LW; Reynolds SJ; Nalugoda F; Ekström AM; Hagström H; Nordenstedt H
Aliment Pharmacol Ther; 2024 May; 59(9):1111-1121. PubMed ID: 38459720
[TBL] [Abstract][Full Text] [Related]
16. Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.
Yanai H; Adachi H; Hakoshima M; Iida S; Katsuyama H
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895151
[TBL] [Abstract][Full Text] [Related]
17. Adherence to a healthy lifestyle including sleep and sedentary behaviors and risk of metabolic dysfunction-associated steatotic liver disease in Chinese adults.
Zhang S; Huo Z; Borné Y; Meng G; Zhang Q; Liu L; Wu H; Gu Y; Sun S; Wang X; Zhou M; Jia Q; Song K; Ma L; Qi L; Niu K
Prev Med; 2024 Jul; 184():107971. PubMed ID: 38657685
[TBL] [Abstract][Full Text] [Related]
18. Exclusive liquor and cocktail consumption is associated with at-risk fibrosis among nonheavy alcohol users with metabolic dysfunction-associated steatotic liver disease.
Ting PS; Lin WT; Huang CK; Lin HY; Tseng TS; Chen PH
Alcohol Clin Exp Res (Hoboken); 2024 Jan; 48(1):88-97. PubMed ID: 38206286
[TBL] [Abstract][Full Text] [Related]
19. Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States.
Ochoa-Allemant P; Marrero JA; Serper M
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38051551
[TBL] [Abstract][Full Text] [Related]
20. Different Associations of Coffee Consumption with the Risk of Incident Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Liver Fibrosis.
Lee JH; Park J; Ahn SB
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
